Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05469165
PHASE2
Serotonin Receptor Blockers in Ischemic Mitral Regurgitation
Sponsor: Laval University
View on ClinicalTrials.gov
Summary
This study is intended to investigate the effect of cyproheptadine (a 5HT2B receptor blocker) on mitral regurgitation severity.
Official title: Blocking the Effects of Serotonin to Prevent Ischemic Mitral Regurgitation: a Randomized Trial (CYPRO-MR)
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
214
Start Date
2023-06-20
Completion Date
2027-09
Last Updated
2023-11-15
Healthy Volunteers
No
Conditions
Interventions
DRUG
Cyproheptadine 4 Mg Oral Tablet
Cyproheptadine treatment for 3 months
OTHER
Placebo
Placebo administration for 3months
Locations (1)
Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval
Québec, Canada